MedPath
TGA Approval

Hospira Dacarbazine for Injection USP, 200 mg vial (142149)

142149

Hospira Dacarbazine for Injection USP, 200 mg vial

Hospira Australia Pty Ltd

July 16, 2007

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

dacarbazine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Hospira Dacarbazine for Injection USP, 200 mg vial (142149) - TGA 批准文号 | MedPath